Skip to main content
HRZN $5.05 +1.00%
HRZN logo

HRZN · Horizon Technology Finance Corp

Track HRZN — free
$5.05 +0.05 (+1.00%) At close · Aug 18
Market Cap
$335.17M
Shares
67.03M
All earnings calls

Earnings call · FY2025 Q4

Horizon Technology Finance Corp Q4 FY2025 Earnings Call

Horizon Technology Finance Corp Q4 FY2025 Earnings Call

Concluded Mar 4, 2026 Audio replay
Mar 4, 2026 31:12 44 turns
Period
FY2025 Q4
Runtime
31:12
Sources
5 artifacts

Executive readout · one minute

What matters this quarter

HRZN reported Q4 2025 NII of $0.18 per share and NAV per share of $6.98, with the portfolio returning to growth ($647.2M) and a debt portfolio yield of 14.3%. The company is moving toward closing its delayed MRCC merger in early 2026 and declared $0.06/month distributions for April–June 2026.

Portfolio growth and originations 65 Merger with MRCC / Monroe Capital 23 Net investment income and dividend coverage 15 Portfolio yield 10 Public company / small-cap financing opportunity 5

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes
  • “I could not be more excited for Horizon Technology Finance Corporation's future.”
  • “We achieved a portfolio yield on debt investments of over 14% for the fourth quarter and nearly 16% for the full year 2025, once again at or near the top of the BDC industry.”
  • “we have been able to successfully lay the groundwork for Horizon Technology Finance Corporation to succeed over the longer term”
  • “we remain excited for our long-term future growth given our numerous strengths including our portfolio yield remains among the industry's highest”

Research coverage

5 live sources

Switch sources without leaving this page or losing your listening position.

Net income · derived Q4 $8.83M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Debt portfolio yield of 14.3% in Q4 and 15.8% for full-year 2025, described as among the highest in the BDC industry.
  • Committed and approved backlog grew to $154M at year-end, up from $119M at end of Q3, with $82.5M in new awarded venture loan transactions.
  • Portfolio returned to growth in Q4 to $647M, funded nine loans totaling $102.5M, and two pipeline loans (HealthOS and Osseo) have already closed in 2026.
  • Liquidity is strong with $142.7M cash and $329.0M credit facility capacity as of Dec. 31, 2025.
  • Q4 nonaccruals declined quarter-over-quarter (from four to three).
  • Undistributed spillover income of $0.65 per share provides cushion above the declared distribution.

Risks & pressure points

  • Q4 NII of $0.18/share was down from $0.27/share in the prior-year quarter, and full-year NII declined to $1.05/share from $1.32/share.
  • Total investment income fell to $20.7M from $23.5M year-over-year, driven by a smaller debt investment portfolio.
  • NAV per share was modestly lower as Q4 distributions paid exceeded NII.
  • The MRCC merger was delayed into 2026 due to the Q4 government shutdown, pushing out the anticipated scale benefits.
  • Realized losses were recorded in Q4, and three portfolio companies remained on nonaccrual.
  • Dollar-weighted annualized yield on debt investments declined to 14.3% in Q4 from 14.9% in the prior-year quarter.

Key moments

Jump directly to management's words in the synchronized transcript.

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Dividend / share
$0.06
Full-screen source Call document